Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nancy E. Reinhalter"'
Autor:
Catherine A. Vicary, Steven N. Warthan, James M. Pluda, John Ruedy, Timothy P. Cooley, Nancy E. Reinhalter, Julio S. G. Montaner, Robert Yarchoan, Mark A. Wainberg, Joseph B. Quinn, Laura E. Shay, Hilary M. Hirst, Marc Rubin, Geoffrey J. Yuen
Publikováno v:
Journal of Infectious Diseases. 171:1438-1447
In a phase I/II trial assessing the toxicity, pharmacokinetics, and activity of the (-)enantiomer of 2'-deoxy-3'-thiacytidine (3TC, lamivudine), 97 patients with AIDS or advanced human immunodeficiency virus (HIV) disease were administered 3TC at 0.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db46ba8ad260e85d3e389f2061c9dcd
https://doi.org/10.1093/infdis/171.6.1438
https://doi.org/10.1093/infdis/171.6.1438
Autor:
Eugenie Coakley, Laureen M. Kunches, Anne B. Morris, Nancy E. Reinhalter, Ayodeji Marquis, John M. Mazzullo, Calvin J. Cohen
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 28(2)
Background: A new enteric-coated (EC) didanosine (ddl) formulation (Videx EC; Bristol-Myers Squibb, Princeton, NJ, U.S.A.) may be better tolerated than the tablet form because it lacks the buffer component thought to be responsible for diarrhea and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d80fee31e35a74574f57db9102ebbdf
https://pubmed.ncbi.nlm.nih.gov/11588508
https://pubmed.ncbi.nlm.nih.gov/11588508